Improvement of lung mechanics by exogenous surfactant: Effect of prior application of high positive end-expiratory pressure

British Journal of Anaesthesia

Volumn 85, Issue 5, 2000, Pages 752-756

  Hartog, A ^a   Gommers, D ^a   Haitsma, J J ^a   Lachmann, B ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Lung, lavage; Lung, surfactants; Models, respiratory distress; Ventilation, mechanical

Indexed keywords

ENFLURANE; LUNG SURFACTANT; NITROUS OXIDE; OXYGEN; PANCURONIUM BROMIDE; PENTOBARBITAL; PLASMA PROTEIN;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; BREATHING RATE; CONTROLLED STUDY; DISEASE MODEL; LUNG ALVEOLUS OXYGEN TENSION; LUNG ALVEOLUS PROTEINOSIS; LUNG ALVEOLUS WALL; LUNG COLLAPSE; LUNG COMPLIANCE; LUNG INJURY; LUNG LAVAGE; LUNG MECHANICS; LUNG VENTILATION; MALE; NONHUMAN; POSITIVE END EXPIRATORY PRESSURE; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; TOTAL LUNG CAPACITY; VENTILATOR;

EID: 0033760708     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/85.5.752     Document Type: Article

References (19)

1. Tidal ventilation at low airway pressures can augment lung injury
2. Modes of artificial ventilation in severe respiratory distress syndrome: Lung function and morphology in rabbits after wash-out of alveolar surfactant
3. Comparison of exogenous surfactant therapy, mechanical ventilation with high end-expiratory pressure and partial liquid ventilation
4. Ventilator-induced lung injury: Lessons from experimental studies
5. Surfactant impairment after mechanical ventilation with large alveolar surface area changes and effects of positive end-expiratory pressure
6. In vivo evaluation of the inhibitory capacity of human plasma on exogenous surfactant function
7. In surfactant deficiency application of the open lung concept' prevents protein leakage and attenuates changes in lung mechanics
8. Pathology and pathophysiology of neonatal surfactant deficiency ('respiratory distress syndrome', 'hyaline membrane disease')
9. Surfactant replacement therapy in the experimental acute respiratory distress syndrome (ARDS)
10. Dose-response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS)
11. Bovine surfactant therapy for patients with acute respiratory distress syndrome
12. In vivo lung lavage as an experimental model of the respiratory distress syndrome
13. Exogenous surfactant therapy increases static lung compliance, and cannot be assessed by measurements of dynamic compliance alone
14. Degradation of surfactant associated protein B (SP-B) during in vitro conversion of large into small surfactant aggregates
15. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
16. Mechanical influences on water accumulation in the lungs
17. Alveolar surfactant aggregate conversion in ventilated normal and injured lungs
18. Surfactant inactivation in adult respiratory distress syndrome
19. Surfactant replacement in adult respiratory distress syndrome